African green monkey kidney (Vero) cells provide an alternative host cell system for influenza A and B viruses

Journal of Virology

Volumn 70, Issue 8, 1996, Pages 5519-5524

  Govorkova, E A ^a,b   Murti, G ^a   Meignier, B ^c   De Taisne, C ^c   Webster, R G ^a,d  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b D I IVANOVSKY INSTITUTE OF VIROLOGY   (Russian Federation)

^c Pasteur Merieux Connaught Grp   (France)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; HOST CELL; INFLUENZA VIRUS A; INFLUENZA VIRUS B; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN SYNTHESIS; SEQUENCE HOMOLOGY; VERO CELL; VIRUS CULTURE; VIRUS ISOLATION; VIRUS REPLICATION;

EID: 0029945540     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.8.5519-5524.1996     Document Type: Article

References (32)

1. Carroll, S. M., and J. C. Paulson. 1985. Differential infection of receptor-modified host cells by receptor-specific influenza viruses. Virus Res. 3:165-173.
2. Demidova, S. A., V. N. Gadashevich, F. M. Kirillova, I. M. El-Shinnavi, Z. I. Rovnova, and A. A. Tsareva. 1979. Isolation and study of influenza A viruses in different cell cultures. Vopr. Virusol 4:346-352. (In Russian.)
3. Frank, A. L., R. B. Couch, C. A. Griffits, and B. D. Baxter. 1979. Comparison of different tissue cultures for isolation and quantitation of influenza and parainfluenza viruses. J. Clin. Microbiol. 10:32-36.
4. Govorkova, E. A., N. V. Kaverin, L. V. Gubareva, B. Meignier, and R. G. Webster. 1995. Replication of influenza A viruses in a green monkey kidney continuous cell line (Vero). J. Infect. Dis. 172:250-253.
5. Gubareva, L. V., J. M. Wood, W. J. Meyer, J. M. Katz, J. S. Robertson, D. Major, and R. G. Webster. 1994. Codominant mixture of viruses in reference strains of influenza virus due to host cell variation. Virology 199:89-97.
6. Hayden, F. G., K. M. Cote, and R. G. Douglas. 1980. Plaque inhibition assay for drug susceptibility testing of influenza viruses. Antimicrob. Agents Chemother. 17:865-870.
7. Hinshaw, V. S., C. W. Olsen, N. Dybdahl-Sissoko, and D. Evans. 1994. Apoptosis: a mechanism of cell killing by influenza A and B viruses. J. Virol. 68:3667-3673.
8. Kärber, G. 1931. Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Arch. Exp. Pathol. Pharmakol. 162:480-483.
9. Katz, J. M., C. W. Naeve, and R. G. Webster. 1987. Host cell mediated variation in H3N2 influenza viruses. Virology 156:386-395.
10. Katz, J. M., M. Wang, and R. G. Webster. 1990. Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus. J. Virol. 64:1808-1811.
11. Katz, J. M., and R. G. Webster. 1992. Amino acid sequence identity between the HA1 of influenza A (H3N2) viruses grown in mammalian and primary chick kidney cells. J. Gen. Virol. 73:1159-1165.
12. Kaverin, N. V., and R. G. Webster. 1995. Impairment of multicycle influenza virus growth in Vero (WHO) cells by loss of trypsin activity. J. Virol. 69: 2700-2703.
13. Kilbourne, E. D. 1987. Cytopathogenesis and cyto-pathology of influenza virus infection of cells in culture, p. 89-110. In E. D. Kilbourne (ed.), Influenza. Plenum Publishing Corp., New York.
14. Lamb, R. A., S. L. Zebedee, and C. D. Richardson. 1985. Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface. Cell 40:627-633.
15. Lau, S. C., and C. Scholtissek. 1995. Abortive infection of Vero cells by an influenza A virus (FPV). Virology 212:225-231.
16. Montagnon, B. J., B. Fanget, and A. J. Nicolas. 1987. The large-scale cultivation of Vero cells in microcarrier culture for virus vaccine production. Preliminary results for killed poliovirus vaccine. Dev. Biol. Stand. 1987:47-55.
17. Monto, A. S., H. F. Maassab, and E. R. Bryan. 1981. Relative efficacy of embryonated eggs and cell culture for isolation of contemporary influenza viruses. J. Clin. Microbiol. 13:233-235.
18. Murphy, B. R., and L. Potash. Personal communication.
19. Nakamura, K., and M. Homma. 1981. Protein synthesis in Vero cells abortively infected with influenza B virus. J. Gen. Virol. 56:199-202.
20. Oxford, J. S., R. Newman, T. Corcoran, J. Bootman, D. Major, P. Yates, J. Robertson, and G. C. Schild. 1991. Direct isolation in eggs of influenza A (H1N1) and B viruses with hemagglutinins of different antigenic and amino acid composition. J. Gen. Virol. 72:185-189.
21. Oxford, J. S., G. C. Schild, T. Corcoran, R. Newman, D. Major, J. Robertson, J. Bootman, P. Higgins, W. Al-Nakib, and D. A. J. Tyrrel. 1990. A host cell-selected variant of influenza B virus with a single nucleotide substitution in HA affecting a potential glycosylation site was attenuated in virulence for volunteers. Arch. Virol. 110:37-46.
22. Rey, O., and D. P. Nayak. 1992. Nuclear retention of M1 protein in a temperature-sensitive mutant of influenza (A/WSN/33) virus does not affect nuclear export of viral ribonucleoproteins. J. Virol. 66:5815-5824.
23. Robertson, J. S., J. S. Bootman, C. Nicolson, D. Major, E. W. Robertson, and J. M. Wood. 1990. The hemagglutinin of influenza B virus present in clinical material is a single species identical to that of mammalian cell-grown virus. Virology 179:35-40.
24. Robertson, J. S., C. W. Naeve, R. G. Webster, J. S. Bootman, R. Newman, and G. C. Schild. 1985. Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs. Virology 143:166-174.
25. Rogers, G. N., and J. C. Paulson. 1983. Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology 127:361-373.
26. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
27. Schepetiuk, S. K., and T. Kok. 1993. The use of MDCK, MEK and LLC-MK2 cell lines with enzyme immunoassay for the isolation of influenza and parainfluenza viruses from clinical specimens. J. Virol. Methods 42:241-250.
28. Schild, G. C., J. S. Oxford, J. C. de Jong, and R. G. Webster. 1983. Evidence for host-cell selection of influenza virus antigenic variants. Nature (London) 303:706-709.
29. Takizawa, T., S. Matsukawa, Y. Higuchi, S. Nakamura, Y. Nakanishi, and R. Fukuda. 1993. Induction of programmed cell death (apoptosis) by influenza virus infection in tissue culture cells. J. Gen. Virol. 74:2347-2355.
30. Valette, M., J. P. Allard, M. Aymard, and V. Millet. 1993. Susceptibilities to rimantadine of influenza A/H1N1 and A/H3N2 viruses isolated during the epidemics of 1988 to 1989 and 1989 to 1990. Antimicrob. Agents Chemother. 37:2239-2240.
31. Wyllie, A. H., J. F. R. Kerr, and A. R. Currie. 1980. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68:251-306.
32. Zuckerman, M. A., R. J. Cox, and J. S. Oxford. 1994. Attenuation of virulence in influenza B viral infection of volunteers. J. Infect. Dis. 28:41-48.